메뉴 건너뛰기




Volumn 15, Issue 10, 2013, Pages 1151-1160

Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-6181

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GNE 618; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINIC ACID; UNCLASSIFIED DRUG;

EID: 84887050309     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.131304     Document Type: Article
Times cited : (72)

References (31)
  • 1
    • 84858604270 scopus 로고    scopus 로고
    • Metabolic reprogramming: A cancer hallmark even Warburg did not anticipate
    • Ward PS and Thompson CB (2012). Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21(3), 297-308.
    • (2012) Cancer Cell , vol.21 , Issue.3 , pp. 297-308
    • Ward, P.S.1    Thompson, C.B.2
  • 7
    • 79957955614 scopus 로고    scopus 로고
    • NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism
    • Burgos ES (2011). NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism. Curr Med Chem 18(13), 1947-1961.
    • (2011) Curr Med Chem , vol.18 , Issue.13 , pp. 1947-1961
    • Burgos, E.S.1
  • 8
    • 37549068090 scopus 로고    scopus 로고
    • NAD+/NADH and NADP+/NADPH in cellular functions and cell death: Regulation and biological consequences
    • Ying W (2008). NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 10(2), 179-206.
    • (2008) Antioxid Redox Signal , vol.10 , Issue.2 , pp. 179-206
    • Ying, W.1
  • 9
    • 50949120914 scopus 로고    scopus 로고
    • Nicotinic acid, nicotinamide, and nicotinamide riboside: A molecular evaluation of NAD+ precursor vitamins in human nutrition
    • Bogan KL and Brenner C (2008). Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr 28, 115-130.
    • (2008) Annu Rev Nutr , vol.28 , pp. 115-130
    • Bogan, K.L.1    Brenner, C.2
  • 10
    • 0038614824 scopus 로고
    • Enzymatic synthesis of nicotinamide mononucleotide
    • Preiss J and Handler P (1957). Enzymatic synthesis of nicotinamide mononucleotide. J Biol Chem 225(2), 759-770.
    • (1957) J Biol Chem , vol.225 , Issue.2 , pp. 759-770
    • Preiss, J.1    Handler, P.2
  • 11
    • 70449212074 scopus 로고
    • Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates
    • Preiss J and Handler P (1958). Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates. J Biol Chem 233(2), 488-492.
    • (1958) J Biol Chem , vol.233 , Issue.2 , pp. 488-492
    • Preiss, J.1    Handler, P.2
  • 12
    • 70350538957 scopus 로고    scopus 로고
    • The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: Strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors
    • Watson M, Roulston A, Bélec L, Billot X, Marcellus R, Bédard D, Bernier C, Branchaud S, Chan H, Dairi K, et al. (2009). The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors. Mol Cell Biol 29(21), 5872-5888.
    • (2009) Mol Cell Biol , vol.29 , Issue.21 , pp. 5872-5888
    • Watson, M.1    Roulston, A.2    Bélec, L.3    Billot, X.4    Marcellus, R.5    Bédard, D.6    Bernier, C.7    Branchaud, S.8    Chan, H.9    Dairi, K.10
  • 13
    • 38149105811 scopus 로고    scopus 로고
    • The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor
    • Holen K, Saltz LB, Hollywood E, Burk K, and Hanauske AR (2008). The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor. Invest New Drugs 26(1), 45-51.
    • (2008) Invest New Drugs , vol.26 , Issue.1 , pp. 45-51
    • Holen, K.1    Saltz, L.B.2    Hollywood, E.3    Burk, K.4    Hanauske, A.R.5
  • 15
    • 14844291424 scopus 로고    scopus 로고
    • Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: An ECSG/EORTC study
    • Ravaud A, Cerny T, Terret C, Wanders J, Bui BN, Hess D, Droz JP, Fumoleau P, and Twelves C (2005). Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study. Eur J Cancer 41(5), 702-707.
    • (2005) Eur J Cancer , vol.41 , Issue.5 , pp. 702-707
    • Ravaud, A.1    Cerny, T.2    Terret, C.3    Wanders, J.4    Bui, B.N.5    Hess, D.6    Droz, J.P.7    Fumoleau, P.8    Twelves, C.9
  • 16
    • 77951887249 scopus 로고    scopus 로고
    • Safety and efficacy of NAD depleting cancer drugs: Results of a phase I clinical trial of CHS 828 and overview of published data
    • von Heideman A, Berglund A, Larsson R, and Nygren P (2010). Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data. Cancer Chemother Pharmacol 65(6), 1165-1172.
    • (2010) Cancer Chemother Pharmacol , vol.65 , Issue.6 , pp. 1165-1172
    • von Heideman, A.1    Berglund, A.2    Larsson, R.3    Nygren, P.4
  • 17
    • 0014960271 scopus 로고
    • Uptake and metabolism of nicotinic acid by human blood platelets. Effects of structure analogs and metabolic inhibitors
    • Gaut ZN and Solomon HM (1970). Uptake and metabolism of nicotinic acid by human blood platelets. Effects of structure analogs and metabolic inhibitors. Biochim Biophys Acta 201(2), 316-322.
    • (1970) Biochim Biophys Acta , vol.201 , Issue.2 , pp. 316-322
    • Gaut, Z.N.1    Solomon, H.M.2
  • 18
    • 77953408297 scopus 로고    scopus 로고
    • A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor
    • Olesen UH, Thougaard AV, Jensen PB, and Sehested M (2010). A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor. Mol Cancer Ther 9(6), 1609-1617.
    • (2010) Mol Cancer Ther , vol.9 , Issue.6 , pp. 1609-1617
    • Olesen, U.H.1    Thougaard, A.V.2    Jensen, P.B.3    Sehested, M.4
  • 20
    • 66449111040 scopus 로고    scopus 로고
    • High-throughput generation of tagged stable cell lines for proteomic analysis
    • Torres JZ, Miller JJ, and Jackson PK (2009). High-throughput generation of tagged stable cell lines for proteomic analysis. Proteomics 9(10), 2888-2891.
    • (2009) Proteomics , vol.9 , Issue.10 , pp. 2888-2891
    • Torres, J.Z.1    Miller, J.J.2    Jackson, P.K.3
  • 22
    • 29344465338 scopus 로고    scopus 로고
    • Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients
    • Yauch RL, Januario T, Eberhard DA, Cavet G, Zhu W, Fu L, Pham TQ, Soriano R, Stinson J, Seshagiri S, et al. (2005). Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res 11(24), 8686-8698.
    • (2005) Clin Cancer Res , vol.11 , Issue.24 , pp. 8686-8698
    • Yauch, R.L.1    Januario, T.2    Eberhard, D.A.3    Cavet, G.4    Zhu, W.5    Fu, L.6    Pham, T.Q.7    Soriano, R.8    Stinson, J.9    Seshagiri, S.10
  • 23
    • 77951820899 scopus 로고    scopus 로고
    • Fast and SNP-tolerant detection of complex variants and splicing in short reads
    • Wu TD and Nacu S (2010). Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 26(7), 873-881.
    • (2010) Bioinformatics , vol.26 , Issue.7 , pp. 873-881
    • Wu, T.D.1    Nacu, S.2
  • 24
    • 77958471357 scopus 로고    scopus 로고
    • Differential expression analysis for sequence count data
    • Anders S and Huber W (2010). Differential expression analysis for sequence count data. Genome Biol 11(10), R106.
    • (2010) Genome Biol , vol.11 , Issue.10
    • Anders, S.1    Huber, W.2
  • 25
    • 84873291018 scopus 로고    scopus 로고
    • Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: Metabolic basis and potential clinical implications
    • Tan B, Young DA, Lu Z-H, Wang T, Meier TI, Shepard RL, Roth K, Zhai Y, Huss K, Kuo M-S, et al. (2013). Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications. J Biol Chem 288(5), 3500-3511.
    • (2013) J Biol Chem , vol.288 , Issue.5 , pp. 3500-3511
    • Tan, B.1    Young, D.A.2    Lu, Z.-H.3    Wang, T.4    Meier, T.I.5    Shepard, R.L.6    Roth, K.7    Zhai, Y.8    Huss, K.9    Kuo, M.-S.10
  • 26
    • 84863090408 scopus 로고    scopus 로고
    • Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells
    • Bowlby SC, Thomas MJ, D'Agostino RB Jr, and Kridel SJ (2012). Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells. PLoS One 7(6), e40195.
    • (2012) PLoS One , vol.7 , Issue.6
    • Bowlby, S.C.1    Thomas, M.J.2    D'Agostino Jr., R.B.3    Kridel, S.J.4
  • 28
    • 84868588684 scopus 로고    scopus 로고
    • Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition
    • Cea M, Cagnetta A, Fulciniti M, Tai Y-T, Hideshima T, Chauhan D, Roccaro A, Sacco A, Calimeri T, Cottini F, et al. (2012). Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition. Blood 120(17), 3519-3529.
    • (2012) Blood , vol.120 , Issue.17 , pp. 3519-3529
    • Cea, M.1    Cagnetta, A.2    Fulciniti, M.3    Tai, Y.-T.4    Hideshima, T.5    Chauhan, D.6    Roccaro, A.7    Sacco, A.8    Calimeri, T.9    Cottini, F.10
  • 30
    • 0242526050 scopus 로고    scopus 로고
    • FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis
    • Hasmann M and Schemainda I (2003). FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63(21), 7436-7442.
    • (2003) Cancer Res , vol.63 , Issue.21 , pp. 7436-7442
    • Hasmann, M.1    Schemainda, I.2
  • 31
    • 79954878322 scopus 로고    scopus 로고
    • Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas
    • Olesen UH, Hastrup N, and Sehested M (2011). Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas. APMIS 119(4-5), 296-303.
    • (2011) APMIS , vol.119 , Issue.4-5 , pp. 296-303
    • Olesen, U.H.1    Hastrup, N.2    Sehested, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.